In this context, a novel approach to tumor therapy has been suggested, namely the utilisation of near-infrared (NIR) light-responsive polymer nanoparticles (CPNs) conjugated with TRPA1 inhibitors [142]. Here, TRPA1 is linked to neoplasm.